Head of Global Out-Licensing – B2B Organization
Zentiva
About this role
Senior leader role at Zentiva responsible for the global out-licensing function, focused on expanding the company’s pharmaceutical products into new markets. The position combines strategic oversight, commercial leadership and P&L accountability while leading a global team and developing partner relationships. It sits within an international generics/branded generics organization committed to growth and market expansion.
Skills
Qualifications
About Zentiva
zentiva.comWe develop, produce, and deliver high-quality, affordable medicines to more than 100 million people across Europe.
Recent company news
Advent InternationalZentiva, a leading European generics pharmaceutical company, announces sale from Advent to GTCR
Sep 11, 2025
European Pharmaceutical ReviewEuropean generics firm Zentiva sold in $4.8bn private equity deal
Sep 16, 2025
ReutersPrivate equity firm Advent to sell generic drugmaker Zentiva to GTCR
Sep 11, 2025
Fierce PharmaChicago private equity firm inks €4.1B purchase of former Sanofi generics unit Zentiva: FT
Sep 11, 2025
Bloomberg.comGTCR in Talks for Private Debt to Fund Bid for Drugmaker Zentiva
Aug 27, 2025
About Zentiva
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Zentiva.
Salary
$205k – $271k
per year
More jobs at Zentiva
Similar Jobs
Out-Licensing Manager
Eva Pharma
AVP Finance, Head of Product Control, Global Markets TD Securities
TD Bank Group
Global Desk Head - Panamax
Rio Tinto
Global Head of Media Performance
Amadeus IT Group
Taiwan Field Service Organization Head, Applied Global Services (AGS)
Applied Materials
VP, Global Franchise Head – Hematology asset, Lymphoma & Leukemia
AstraZeneca